Total words: 3135 | 2-word phrases: 828 | 3-word phrases: 933 | 4-word phrases: 969
Title | Try to keep the title under 60 characters (48 characters) Remodulin (treprostinil injection) PAH Treatment |
Description | Try to keep the meta description between 50 - 160 characters (146 characters) Remodulin is a continuous pump therapy available for treating pulmonary arterial hypertension (PAH). Learn about benefits, pump options, and more. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (47 characters) What would you like to explore about Remodulin? |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | remodulin | 57 | 14.07% | ||||||
2 | the | 49 | 12.10% | ||||||
3 | of | 47 | 11.60% | ||||||
4 | to | 36 | 8.89% | ||||||
5 | or | 31 | 7.65% | ||||||
6 | your | 29 | 7.16% | ||||||
7 | with | 26 | 6.42% | ||||||
8 | is | 25 | 6.17% | ||||||
9 | and | 24 | 5.93% | ||||||
10 | are | 22 | 5.43% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program | Whois | fda.gov |
2 | https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program | Whois | fda.gov |
3 | https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program | Whois | fda.gov |
4 | https://www.unither.com/privacy.html | Whois | unither.com |
5 | https://www.unither.com/terms | Whois | unither.com |
6 | https://www.unither.com/contact.html | Whois | unither.com |
7 | https://unsubscribe.unither.com/ | Whois | unither.com |